The ???Uber of Biotech??? Gets Back To Work

Hilary Kramer discusses biotech stocks, outlines their risks and compares the industry leader to Uber.

  • by:
  • 08/21/2022

By Hilary Kramer

Forget the ???FANG??? group of the biggest technology companies. When you want pure disruptive innovation and a wild Wall Street ride, biotech remains the place to be.

I love these stocks. When they???re rallying, they???re a play on pure innovation. This is because they generate wealth for shareholders on what boils down to the confidence that medical science will keep advancing.

The upside is practically infinite. After all, most computer tools only improve life in increments, make us a little more productive day by day and expand our existing reach.

Biotech, at its most visionary, saves human lives that otherwise would be cut short one way or another. That transcends normal valuations.

Companies that develop those therapies can one day be worth the price of progress itself. And when that mood catches on, the stocks soar.

We???ve seen a few of these stocks on my Turbo Trader list soar 50 percent year to date. That???s true transformative upside. It???s exhilarating.

Click here to read more.

Image:
ADVERTISEMENT

Opinion

View All

'State-sanctioned sexual assault': Trans cops allowed to strip-search detained women in the UK

"This is state-sanctioned sexual assault and police chiefs have lost their mind bringing this in. The...

South African health officials warn public against sex change drugs for minors

"The EXCO has issued an advisory to practitioners that the off-use label drugs needs to be done with ...

German trans-identified male police officer accused of drugging, sexually abusing colleagues

The officer, identified as 27-year-old Judy S., a biological male who identifies as transgender, has ...

STEPHEN DAVIS: US Department of Education says using AI at school could lead to racism

“The growing use of AI in schools, including for instructional and school safety purposes, and AI’s a...